GlassScriptPhysician profile
Jason N Salamon
NPI 1467748202
$17,073.61
in general payments reported to CMS, 2019-2025
48 companies · $2,099 in 2025
The $2,099 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,181 · 2020: $2,024 · 2021: $2,205 · 2022: $2,790 · 2023: $2,957 · 2024: $2,817 · 2025: $2,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,826 · Education: $32.27 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,825.79 |
| Education | $32.27 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,747.31 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,536.30 | 2019-2025 | |
| Pfizer INC. | $1,487.77 | 2019-2025 | |
| Boston Scientific Corporation | $1,273.90 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Janssen Pharmaceuticals, INC | $940.57 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $871.01 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $859.94 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $738.91 | 2019-2025 | Farxiga, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $674.64 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $668.09 | 2021-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $665.52 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $566.98 | 2020-2025 | Onpattro, Amvuttra |
| Arbor Pharmaceuticals, INC. | $561.56 | 2019-2021 | |
| Novo Nordisk INC | $498.18 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Baxter Healthcare | $422.00 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $373.61 | 2019-2024 | Livalo |
| Esperion Therapeutics, INC. | $309.95 | 2021-2025 | Nexletol |
| Irhythm Technologies, INC. | $286.70 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Kestra Medical Technology Services, INC. | $277.33 | 2022-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $263.52 | 2019-2024 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $202.89 | 2019-2023 | Evkeeza |
| Scpharmaceuticals INC. | $182.00 | 2023-2025 | |
| Heartflow, INC. | $147.46 | 2022-2025 | Ffrct |
| Kiniksa Pharmaceuticals, LTD. | $134.66 | 2022-2023 | Arcalyst |
| Cvrx, INC. | $133.87 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $129.83 | 2020-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Impulse Dynamics (USA) INC. | $113.39 | 2022-2024 | Optimizer, Optimizer |
| Philips North America LLC | $98.18 | 2024-2025 | (5044) Mcot, Extended Holter |
| Althera Pharmaceuticals LLC | $97.40 | 2021-2022 | |
| Bridgebio Pharma, INC. | $92.04 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $88.35 | 2021-2025 | |
| Biosense Webster, INC. | $82.77 | 2019-2023 | Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $77.44 | 2024 | Arcalyst |
| Lundbeck LLC | $72.53 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $64.58 | 2024 | Edarbi, Edarbyclor |
| Lilly USA, LLC | $48.49 | 2024-2025 | Zepbound, Jardiance |
| Lexicon Pharmaceuticals, INC. | $44.51 | 2023-2024 | Inpefa |
| Bardy Diagnostics, INC. | $40.00 | 2020-2021 | |
| Acarix USA INC. | $37.80 | 2024 | Cadscor System |
| Medicure Pharma INC. | $26.62 | 2021 | |
| Inspire Medical Systems, INC. | $23.01 | 2023 | Inspire |
| Watermark Medical, INC. | $18.91 | 2024 | |
| Atricure, INC. | $18.76 | 2021 | |
| Genzyme Corporation | $17.14 | 2024 | |
| Ionis Pharmaceuticals, INC. | $16.38 | 2025 | Tryngolza |
| Glaxosmithkline, LLC. | $15.45 | 2025 | Shingrix, Arexvy |
| Amryt Pharma Holdings LTD | $13.33 | 2021 | |
| Abiomed | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Salamon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.